Floatz logo

Calcium folinate pentahydrate

Thyroid Carcinoma

Institut de Recherches Internationales ServierSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Thyroid Carcinoma cohort.

Asset / SponsorPhaseRating
LENVATINIB
University Medical Center Groningen
Phase 4BB
Olaparib
University Medical Center Groningen
Phase 4BB
gw786034
University Medical Center Groningen
Phase 4B
Pembrolizumab
Merck Sharp & Dohme LLC
Phase 2CCC
Epirubicin
Merck Sharp & Dohme LLC
Phase 2CCC

View all 14 →

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →